These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12410169)

  • 1. [Testis cancer markers. Clinical use].
    Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
    Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Morris MJ; Bosl GJ
    J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of tumor markers in the treatment of germ cell tumor].
    Niwakawa M; Tobisu K
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1159-65. PubMed ID: 11525037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
    Schatte EC; Lerner SP
    J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071
    [No Abstract]   [Full Text] [Related]  

  • 6. Early identification of therapeutic failure in nonseminomatous germ cell tumors by assessing serum tumor marker decline during chemotherapy: still not ready for routine clinical use.
    Toner GC
    J Clin Oncol; 2004 Oct; 22(19):3842-5. PubMed ID: 15302908
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis].
    Canal P; Villeneuve G; Bugat R; Armand JP; Soula G
    Pathol Biol (Paris); 1984 Apr; 32(4):245-50. PubMed ID: 6201806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of serum ferritin level in testicular tumors].
    Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
    Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of tumor markers in the treatment of germ cell tumors].
    Germá Lluch JR; García del Muro X; Galán MC
    Arch Esp Urol; 2000; 53(6):460-8. PubMed ID: 11002513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
    Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
    Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
    Harland SJ
    Br J Urol; 1992 Jun; 69(6):669. PubMed ID: 1379103
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
    J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
    von Eyben FE
    Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.
    Christensen TB; Engbaek F; Marqversen J; Nielsen SI; Kamby C; von der Maase H
    Br J Cancer; 1999 Jul; 80(10):1577-81. PubMed ID: 10408402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.